Navigation Links
Barrow scientist leads insula research
Date:7/7/2010

(PHOENIX, AZ) -- A scientist at Barrow Neurological Institute is leading the global discussion and research on a hidden lobe of the brain called the insula. A.D. "Bud" Craig, PhD, who began studying the often-ignored lobe more than two decades ago, has organized and edited a special edition of the journal Brain Structure and Function dedicated to the emerging medical and scientific interest in the insula.

This special edition contains 21 articles describing the latest research and insights from scientists and clinicians from around the world who recognize the insula as the key to their own field of interest and perhaps human consciousness.

The insula is a prune-sized area located deep within the brain. It was long ignored because scientists could not probe the area with surface electrodes. With the invention of sophisticated brain imaging techniques such as functional magnetic resonance imaging (fMRI) activation of the region has been observed in a surprisingly wide range of studies.

"Rapidly accumulating evidence indicates that this area of the brain is uniquely involved in virtually every human emotion and behavior," says Dr. Craig. "Similarly, clinical evidence indicates that it is crucially involved in a variety of syndromes, including addiction, anxiety, depression, anosognosia, schizophrenia and frontotemporal dementia."

Dr. Craig says that the overall goal of the special issue on the insula in Brain Structure and Function is to provide a solid starting point for new investigators by identifying the issues and opportunities for advances in the knowledge of this unique portion of the human brain.

An "intense" discussion about the role of the insula is urgently needed, says Dr. Craig, because many researchers have not had knowledge of its role and so little had been written about it.

"The insula is finally emerging from its hiding place inside the human brain," says Dr. Craig. "Its central importance to all human feelings and behaviors makes it an extraordinarily important target for potential treatments of many mental dysfunctions, using drugs or sophisticated biofeedback methods."


'/>"/>

Contact: Lynne Reaves
lynne.reaves@chw.edu
602-406-4734
St. Joseph's Hospital and Medical Center
Source:Eurekalert

Related biology news :

1. Barrow scientist receives $450K MDA grant
2. New era of pain drugs advanced by Barrow researcher
3. Barrow researcher finds natural hydrogel helps heal spinal cord
4. Barrow scientist awarded $400,000 grant to study cell associated with intuition and autism
5. Barrow scientists solve 200-year-old scientific debate involving visual illusions
6. Marine scientists return with rare creatures from the deep
7. Scientists find direct line from development to growth
8. UM School of Medicine scientists develop new strategy that may improve cognition
9. Honey as an antibiotic: Scientists identify a secret ingredient in honey that kills bacteria
10. NOAA-supported scientists predict larger than average Gulf dead zone
11. SAGE to publish the Bulletin of the Atomic Scientists
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/9/2017)... March 9, 2017 4Dx has publicly released ... Imaging Workshop at the University of Pennsylvania. Founder and ... deliver the latest data to world leaders in lung ... together leaders at the forefront of the industry to ... "The quality of the imaging is ...
(Date:3/7/2017)... BRIGHTON, England , March 7, 2017 Brandwatch ... been chosen by The Prince,s Trust to uncover insights ... insights across The Trust. The UK,s leading youth charity ... track social campaign results and get a better understanding of the ... ...
(Date:3/6/2017)... March 6, 2017 Mintigo , ... today announced Predictive Sales Coach TM , its ... sales intelligence into Salesforce. This unique AI application ... sales organizations with deep knowledge of their customers ... intelligent engagement. Predictive Sales Coach extends Mintigo,s existing ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... MENLO PARK, Calif., March 23, 2017  BioPharmX ... developing products for the dermatology market, today reported ... Jan. 31, 2017, and will provide an update ... from the year. "We are pleased ... productive year for BioPharmX," said President Anja Krammer. ...
(Date:3/23/2017)... , March 23, 2017  Agriculture technology company Cool ... financing and note conversion to commercialize its Cool Terra ... focused on developing products that are simultaneously profitable as ... in the last 18 months. This latest round of ... Venture Partners. The company,s primary product, ...
(Date:3/22/2017)... March 22, 2017  Ascendis Pharma A/S (Nasdaq: ... TransCon technology to address significant unmet medical needs ... the full year ended December 31, 2016. ... our company as we broadened our pipeline and ... rare disease company with an initial focus on ...
(Date:3/22/2017)... York , March 22, 2017 ... largely fragmented, states a research report by Transparency Market ... Pfizer Inc., Amgen Inc., and AbbVie Inc., accounted for ... 2015. The prominent players in this market are focusing ... their product portfolio, which is likely to lead to ...
Breaking Biology Technology: